Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma

Clinical trial NCT00135200 · COMPLETED

Trial details

NCT number: NCT00135200
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2005-08-01
Primary completion: 2013-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.